Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

Investigator: Karen C. Johnson, MD, MPH. Experience gained in physician education and
smoking cessation interventions on patient behavior. Funded by the University of Tennessee
Medical Group (UTMG). $12,000. 1991 - 1994.
Injury Prevention: Are Smoke Detectors Important? Principal Investigator: Karen C. Johnson,
MD, MPH. Experience with design and implementation of an injury prevention randomized
clinical trial looking at smoke detector acquisition or maintenance by high risk adults in the
medical outpatient clinic at Johns Hopkins Hospital. No extramural funding. 1989 - 1991.
Other Research Projects
Role on Project: Co-Investigator
Treatment of Hot Flashes in Breast Cancer Survivors: A Pilot Study. Principal Investigator:
Margret DeBon, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Susan G.
Komen Foundation: $247,572, 2005- 2008.
Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: Suzanne Satterfield,
MD, DrPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth- Ayerst. $122,050
2001 - 2004.
Heart and Estrogen/progestin Replacement Study II (HERS - II). Principal Investigator: Suzanne
Satterfield, MD, DrPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth-
Ayerst. $184,899. 1998 - 2001.
Heart and Estrogen/progestin Replacement Study (HERS). Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Wyeth- Ayerst.
$1,716,221. 1992 - 1998.
Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by the Eli Lilly
Co. $448,632. 1994 - 1998.
Nicotine Replacement Therapy Products: Prevalence of Use and Sources of Access in Minors.
Principal Investigator: Lisa Klesges, Ph.D., Co-Investigator: Karen C. Johnson, MD, MPH.
Experience gained in assessing the prevalence of use of Nicotine Replacement Therapy in the
community. Funded by the Partnership for Women's and Children's Health, $30,000. 1997 -
1998.
Pharmaceutical Study with Antihypertensive Agents. Principal Investigator: William B. Applegate,
MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Merck & Co., Inc.
$26,700. 1997 - 1998.
Pharmaceutical Study with Anticlaudication Agents. Principal Investigator: Marshall B. Elam,
MD, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by Otsuka America
Pharmaceuticals, Inc. $38,440. 1997 - 1998.
Pharmaceutical Study with Antihypertensive Agents. Principal Investigator: William B.
Applegate, MD, MPH. Co-Investigator: Karen C. Johnson, MD, MPH. Funded by SmithKline
Beecham. $62,370. 1997 - 1998.
Pharmaceutical Study with Antilipid Agents. Principal Investigator: Marshall B. Elam, MD, PhD.
Co-Investigator: Karen C. Johnson, MD, MPH. Project examined the effects of aggressive lipid
lowering on cardiovascular events. Funded by Parke Davis. $337,500. 1995 - 1998.
14